Orris

Bacterial vaginosis treatment

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Here is a comprehensive overview of bacterial vaginosis (BV) treatment based on current authoritative sources:

Bacterial Vaginosis — Treatment

Overview

BV results from replacement of normal Lactobacillus-dominated vaginal flora with a polymicrobial mix (Gardnerella vaginalis, anaerobes, others). It is the most common cause of abnormal vaginal discharge in the US. Over half of affected women are asymptomatic.

First-Line Regimens

DrugRouteDoseDuration
MetronidazoleOral500 mg twice daily7 days
Metronidazole gel 0.75%Intravaginal5 g once daily5 days
Clindamycin cream 2%Intravaginal5 g (100 mg) at bedtime7 days
Clindamycin and metronidazole have equivalent efficacy regardless of regimen (Cochrane review, 2009). Intravaginal routes avoid systemic side effects.

Alternative Regimens

  • Secnidazole (nitroimidazole): single oral 2 g dose — effective and FDA-approved
  • Tinidazole: 1 g/day for 5 days OR 2 g/day for 3 days (oral)
  • Clindamycin oral: 300 mg twice daily for 7 days
  • Clindamycin ovules: 100 mg intravaginally once at bedtime for 3 days
Tinidazole is effective with no serious side effects but is more expensive. — Textbook of Family Medicine 9e

Pregnancy

  • Symptomatic pregnant women may receive the same oral or topical regimens as non-pregnant women
  • Intravaginal clindamycin during pregnancy has not consistently reduced adverse outcomes (preterm birth, spontaneous abortion)
  • Multiple trials of oral metronidazole in pregnancy gave inconsistent results
  • The US Preventive Services Task Force recommends against routine screening of pregnant women for BV
  • Treatment is directed at symptomatic relief rather than improving fetal outcomes

Recurrent BV

  • Recurrence months after treatment is common with both oral and intravaginal regimens
  • Suppressive therapy: twice-weekly intravaginal metronidazole gel significantly reduces recurrences
  • LACTIN-V (L. crispatus CTV-05): weekly vaginal administration reduced recurrent BV rates by ~one-third in a randomized trial
  • Higher-dose topical metronidazole (500 mg suppository vs. 37.5 mg gel) appears more effective

What Doesn't Work

  • Treatment of male sexual partners — no benefit
  • Intravaginal Lactobacillus preparations / probiotics — no proven benefit for restoring flora or treating BV
  • Hydrogen peroxide douching — considered ineffective
  • Triple-sulfonamide cream — considered ineffective

Diagnosis (for context)

The Amsel criteria diagnose BV when 3 of 4 are present:
  1. Vaginal pH > 4.5 (most sensitive: 89%)
  2. Clue cells > 20% on wet mount (74% sensitivity)
  3. Homogeneous gray adherent discharge (79% sensitivity)
  4. Positive whiff test — fishy odor with KOH (67% sensitivity, 93% specificity)
NAATs are also available with high sensitivity and specificity.
Sources: ROSEN's Emergency Medicine; Harrison's Principles of Internal Medicine 22E; Textbook of Family Medicine 9e
This is a shared conversation. Sign in to Orris to start your own chat.